The association between circulating endostatin and a disturbed circadian blood pressure pattern in patients with type 2 diabetes

被引:4
作者
Wuopio, Jonas [1 ]
Ostgren, Carl Johan [2 ]
Lanne, Toste [2 ]
Lind, Lars [3 ]
Ruge, Toralph [4 ]
Carlsson, Axel C. [5 ]
Larsson, Anders [3 ]
Nystrom, Fredrik H. [2 ]
Arnlov, Johan [5 ,6 ]
机构
[1] Mora Cty Hosp, Dept Med, Mora, Sweden
[2] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden
[3] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
[4] Karolinska Univ Hosp, Dept Emergency Med, Stockholm, Sweden
[5] Karolinska Inst, Div Family Med & Primary Care, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden
[6] Dalarna Univ, Sch Hlth & Social Sci, Falun, Sweden
基金
欧盟地平线“2020”; 瑞典研究理事会;
关键词
Ambulatory blood pressure; circadian blood pressure variation; endostatin; non-dipping; type 2 diabetes mellitus; COMMUNITY-BASED COHORTS; INTIMA-MEDIA THICKNESS; COLLAGEN-XVIII; DOWN-SYNDROME; SERUM ENDOSTATIN; ELDERLY FINDINGS; ORGAN DAMAGE; HYPERTENSION; RISK; ANGIOGENESIS;
D O I
10.1080/08037051.2018.1444941
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Endostatin, cleaved from collagen XVIII in the extracellular matrix, is a promising circulating biomarker for cardiovascular damage. It possesses anti-angiogenic and anti-fibrotic functions and has even been suggested to be involved in blood pressure regulation. Less is known if endostatin levels relate to circadian blood pressure patterns. In the present paper we studied the association between circulating levels of endostatin and nocturnal dipping in blood pressure.Methods: We used the CARDIPP-study, a cohort of middle aged, type 2 diabetics (n=593, 32% women), with data on both 24-hour and office blood pressure, serum-endostatin, cardiovascular risk factors, and incident major cardiovascular events. Nocturnal dipping was defined as a >10% difference between day- and night-time blood pressures.Results: Two-hundred four participants (34%) were classified as non-dippers. The mean endostatin levels were significantly higher in non-dippers compared to dippers (meanstandard deviation: 62.6 +/- 1.8 mu g/l vs. 58.7 +/- 1.6 mu g/l, respectively, p=.007). Higher serum levels of endostatin were associated with a diminished decline in nocturnal blood pressure adjusted for age, sex, HbA1c, mean systolic day blood pressure, hypertension treatment, glomerular filtration rate, and prevalent cardiovascular disease (regression coefficient per SD increase of endostatin -0.01, 95% CI, -0.02-(-0.001), p=.03). Structural equation modelling analyses suggest that endostatin mediates 7% of the association between non-dipping and major cardiovascular events.Conclusion: We found an independent association between higher circulating levels of endostatin and a reduced difference between day- and night-time systolic blood pressure in patients with type 2 diabetes. Yet endostatin mediated only a small portion of the association between non-dipping and cardiovascular events arguing against a clinical utility of our findings.
引用
收藏
页码:215 / 221
页数:7
相关论文
共 38 条
[1]   Endostatin: The logic of antiangiogenic therapy [J].
Abdollahi, A ;
Hlatky, L ;
Huber, PE .
DRUG RESISTANCE UPDATES, 2005, 8 (1-2) :59-74
[2]   Non-Dipping and Cardiometabolic Profile: A Study on Normotensive Overweight Middle-Aged Men [J].
Albert, Benjamin B. ;
de Bock, Martin ;
Derraik, Jose G. B. ;
Brennan, Christine M. ;
Biggs, Janene B. ;
Hofman, Paul L. ;
Cutfield, Wayne S. .
HEART LUNG AND CIRCULATION, 2016, 25 (12) :1218-1225
[3]   Serum Endostatin and Risk of Mortality in the Elderly Findings From 2 Community-Based Cohorts [J].
Arnlov, Johan ;
Ruge, Toralph ;
Ingelsson, Erik ;
Larsson, Anders ;
Sundstrom, Johan ;
Lind, Lars .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (11) :2689-2695
[4]   The association between endostatin and kidney disease and mortality in patients with type 2 diabetes [J].
Carlsson, A. C. ;
Ostgren, C. J. ;
Lanne, T. ;
Larsson, A. ;
Nystrom, F. H. ;
Arnlov, J. .
DIABETES & METABOLISM, 2016, 42 (05) :351-357
[5]   Association Between Circulating Endostatin, Hypertension Duration, and Hypertensive Target-Organ Damage [J].
Carlsson, Axel C. ;
Ruge, Toralph ;
Sundstrom, Johan ;
Ingelsson, Erik ;
Larsson, Anders ;
Lind, Lars ;
Arnlov, Johan .
HYPERTENSION, 2013, 62 (06) :1146-1151
[6]   Ambulatory Blood Pressure and Diabetes: Targeting Nondipping [J].
Cuspidi, Cesare ;
Vaccarella, Alvaro ;
Leonetti, Gastone ;
Sala, Carla .
CURRENT DIABETES REVIEWS, 2010, 6 (02) :111-115
[7]   Carotid intima-media thickness and apolipoprotein B/apolipoprotein A-I ratio in middle-aged patients with Type 2 diabetes [J].
Dahlen, E. M. ;
Lanne, T. ;
Engvall, J. ;
Lindstrom, T. ;
Grodzinsky, E. ;
Nystrom, F. H. ;
Ostgren, C. J. .
DIABETIC MEDICINE, 2009, 26 (04) :384-390
[8]  
Distler JHW, 2003, Q J NUCL MED, V47, P149
[9]   Comparison of Intima-Media Thickness of the Carotid Artery and Cardiovascular Disease Risk Factors in Adults With Versus Without the Down Syndrome [J].
Draheim, Christopher C. ;
Geijer, Justin R. ;
Dengel, Donald R. .
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (10) :1512-1516
[10]   The importance of night-time systolic blood pressure in diabetic patients: Dublin Outcome Study [J].
Draman, Mohd S. ;
Dolan, Eamon ;
van der Poel, Lelane ;
Tun, Tommy Kyaw ;
McDermott, John H. ;
Sreenan, Seamus ;
O'Brien, Eoin .
JOURNAL OF HYPERTENSION, 2015, 33 (07) :1373-1377